Dongmei Yan
- Molecular Biology
- Immunology top 10%
- Cancer Research top 10%
- Biomedical Engineering
- Materials Chemistry
- Topics
- Immune cells in cancer (15 papers)Nanoplatforms for cancer theranostics (9 papers)MicroRNA in disease regulation (8 papers)
- Journals
- Nano LettersPLoS ONEBiomaterials
- Partner nations
- ChinaUnited StatesAustria
In The Last Decade
Dongmei Yan
69 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 125
- Molecular Biology 681
- Immunology 252
- Cancer Research 242
- Biomedical Engineering 219
- Materials Chemistry 186
Countries citing papers authored by Dongmei Yan
This map shows the geographic impact of Dongmei Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongmei Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongmei Yan more than expected).
Fields of papers citing papers by Dongmei Yan
This network shows the impact of papers produced by Dongmei Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongmei Yan. The network helps show where Dongmei Yan may publish in the future.
Co-authorship network of co-authors of Dongmei Yan
This figure shows the co-authorship network connecting the top 25 collaborators of Dongmei Yan. A scholar is included among the top collaborators of Dongmei Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongmei Yan. Dongmei Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 10 | |
| 3 | 4 | |
| 4 | 10 | |
| 5 | 3 | |
| 6 | 3 | |
| 7 | 7 | |
| 8 | 5 | |
| 9 | 23 | |
| 10 | 22 | |
| 11 | 0 | |
| 12 | 87 | |
| 13 | 40 | |
| 14 | 9 | |
| 15 | 29 | |
| 16 | 31 | |
| 17 | 19 | |
| 18 | 37 | |
| 19 | Proteomic analysis of macrophages: a potential way to identify novel proteins associated with activation of macrophages for tumor cell killing. | 19 |
| 20 | 25 |
About Dongmei Yan
Dongmei Yan is a scholar working on Immunology, Cancer Research and Toxicology, having authored 73 papers that have together received 1.3k indexed citations. Recurring topics across this work include Immune cells in cancer (15 papers), Nanoplatforms for cancer theranostics (9 papers) and MicroRNA in disease regulation (8 papers). The work is most often cited by research in Cancer Research (242 citations), Immunology (252 citations) and Molecular Biology (681 citations). Dongmei Yan has collaborated with scholars based in China, United States and Austria. Frequent co-authors include Dong Li, Zheng Jin, Xun Zhu, Chunyan Duan, Rongyang Dai, Pei Zhu, Chang Shu, Yuan‐Di Zhao, Mengyao Qin and Jitao Song. Their work appears in journals such as Nano Letters, PLoS ONE and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.